No Mediastinal Lymph Node Dissection Needed in Selected Early NSCLC, Trial Says

(MedPage Today) — Selected patients with early non-small cell lung cancer (NSCLC) did not benefit from mediastinal lymph node dissection (LND), which was associated with longer operations, more blood loss, and longer hospital stay, a randomized…

Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/117046

Author :

Publish date : 2025-08-18 18:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

No Mediastinal Lymph Node Dissection Needed in Selected Early NSCLC, Trial Says

Breastfeeding May Protect Against Early Puberty

Is OTC Birth Control Reaching Patients Who Face Care Barriers?

Related Posts

We evolved to match local micronutrient levels, which may be a problem

Women’s healthcare chronically underfunded, says Melinda French Gates

FDA Probes Harms of COVID Vax in Pregnancy; Whistleblowers Detail Strife Inside NIH

Do Autoantibody Profiles Vary in Dermatomyositis Subtypes?

House Hearing on Kids’ Nutrition Veers Off in Many Directions

Concurrent Durvalumab Shows No Survival Benefit in NSCLC

We evolved to match local micronutrient levels, which may be a problem

Women’s healthcare chronically underfunded, says Melinda French Gates

FDA Probes Harms of COVID Vax in Pregnancy; Whistleblowers Detail Strife Inside NIH

Do Autoantibody Profiles Vary in Dermatomyositis Subtypes?

House Hearing on Kids’ Nutrition Veers Off in Many Directions

Concurrent Durvalumab Shows No Survival Benefit in NSCLC

Make the Diagnosis: These Incredibly Itchy Lesions Have No Systemic Cause. What are They?

Fertility clinics must stop unproven treatments, watchdog warns

Categories

Archives